Search
Stoke Therapeutics Inc
STOKAdd to Watchlist
32.710USD
-0.010-0.03%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.04BMarket Cap
LossP/E TTM
Stoke Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Stoke Therapeutics Inc is 8.28, ranking 153 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -11.44, which is -572.42% below the recent high of 54.03 and -2702.91% above the recent low of -320.57.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.